Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
Biomedicines|October 23, 2021
Transcriptomic Characterization of Postmolar Gestational ChoriocarcinomaConstance Collet, Jonathan Lopez, Christophe Battail, et al.Foot & Ankle International|March 2, 2023
Effect of Vancomycin Applied to the Surgical Site on Fracture Healing in a Diabetic Rat ModelAlexis Hernandez, Ohidur Rahman, Yazan Kadkoy, et al.Histopathology|December 9, 2024
Understanding and overcoming the pitfalls in the diagnosis of pleomorphic and carcinoma ex-pleomorphic adenoma of salivary glandsZiyad Alsugair, Charles Lépine, Maxime Fieux, et al.Pediatric Neurosurgery|December 1, 2020
Awake Mapping of the Auditory Cortex during Tumor Resection in an Aspiring Musical Performer: A Case ReportDavid I Bass, Hillary Shurtleff, Molly Warner, et al.Scientific Reports|October 1, 2020
Deciphering heterogeneity of septic shock patients using immune functional assays: a proof of concept studyChloé Albert Vega, Guy Oriol, François Bartolo, et al.European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Predictive factors of outcome in poorly differentiated thyroid carcinomasChristelle de la Fouchardière, Myriam Decaussin-Petrucci, Julien Berthiller, et al.The American Journal of Surgical Pathology|March 18, 2024
Characterization of a Molecularly Distinct Subset of Oncocytic Pleomorphic Adenomas/Myoepitheliomas Harboring Recurrent ZBTB47-AS1::PLAG1 Gene FusionZiyad Alsugair, Jimmy Perrot, Françoise Descotes, et al.Gynecologic Oncology|February 6, 2026
Eco-responsible and rational interval debulking surgery for high-grade ovarian carcinomas: An observational, ambispective cohort studySarah Hodent, Naoual Bakrin, Pascal Rousset, et al.The EMBO Journal|July 28, 2018
Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosisJoel S Riley, Giovanni Quarato, Catherine Cloix, et al.Cancer Chemotherapy and Pharmacology|April 3, 2023
A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trialAlicja Puszkiel, Benoit You, Léa Payen, et al.Pageof 11